Organization
Encell
4 clinical trials
Clinical trial
An Open, Dose-escalation, Phase 1b Clinical Trial to Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A (CMT1A)Status: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase 1/2 Trial to Evaluate the Efficacy and Safety of EN001 in Patients With Duchenne Muscular DystrophyStatus: Not yet recruiting, Estimated PCD: 2025-11-01
Clinical trial
Open-label, Dose-escalation, Phase 1 Clinical Trial to Determine the Safety and Dose of EN001 in Patients With Charcot-Marie-Tooth Disease (CMT) Type 1AStatus: Completed, Estimated PCD: 2022-12-20
Clinical trial
Open-label, Dose-escalation, Phase 1 Clinical Trial to Determine the Safety and Dose of EN001 in Patients With Duchenne Muscular Dystrophy(DMD)Status: Completed, Estimated PCD: 2022-12-28